This page contains brief information about calaspargase pegol-mknl and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Calaspargase pegol-mknl is approved to treat:
- Acute lymphoblastic leukemia in children and young adults aged 1 month to 21 years. It is used with combination chemotherapy.
Calaspargase pegol-mknl is also being studied in the treatment of other types of cancer.
More About Calaspargase Pegol-mknl
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Clinical Trials Accepting Patients
Find Clinical Trials for Calaspargase Pegol-mknl - Check for trials from NCI's list of cancer clinical trials now accepting patients.